Morgan Stanley Takeda Pharmaceutical CO LTD Transaction History

Morgan Stanley

$1.49 Trillion
Q2 2025

A detailed history of Morgan Stanley transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Morgan Stanley holds 7,619,590 shares of TAK stock, worth $111 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

7,619,590

Previous 5,702,524 33.62%

Holding current value

$111 Million

Previous $84.8 Million 38.92%

% of portfolio

0.01%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 15, 2025	BUY	$13.71 - $15.46 $26.3 Million - $29.6 Million	1,917,066 Added 33.62%	7,619,590 $118 Million
Q1 2025 May 15, 2025	BUY	$12.89 - $15.19 $1.31 Million - $1.54 Million	101,699 Added 1.82%	5,702,524 $84.8 Million
Q4 2024 Feb 14, 2025	BUY	$13.01 - $14.43 $3.2 Million - $3.55 Million	245,928 Added 4.59%	5,600,825 $74.2 Million
Q3 2024 May 14, 2025	BUY	$13.0 - $15.08 $4.78 Million - $5.55 Million	367,945 Added 7.38%	5,354,897 $76.1 Million
Q3 2024 Nov 14, 2024	BUY	$13.0 - $15.08 $4.78 Million - $5.55 Million	367,945 Added 7.38%	5,354,897 $76.1 Million
Q2 2024 May 14, 2025	SELL	$12.6 - $13.67 $7.73 Million - $8.39 Million	-613,873 Reduced 10.96%	4,986,952 $64.5 Million
Q2 2024 Oct 17, 2024	SELL	$12.6 - $13.67 $109,254 - $118,532	-8,671 Reduced 0.17%	4,986,952 $64.5 Million
Q2 2024 Aug 14, 2024	SELL	$12.6 - $13.67 $109,254 - $118,532	-8,671 Reduced 0.17%	4,986,952 $64.5 Million
Q1 2024 Oct 17, 2024	BUY	$13.89 - $15.04 $120,440 - $130,411	8,671 Added 0.17%	4,995,623 $69.4 Million
Q1 2024 Aug 16, 2024	BUY	$13.89 - $15.04 $2.06 Million - $2.23 Million	148,088 Added 3.05%	4,995,623 $69.4 Million
Q1 2024 May 15, 2024	BUY	$13.89 - $15.04 $2.06 Million - $2.23 Million	148,088 Added 3.05%	4,995,623 $69.4 Million
Q4 2023 Aug 16, 2024	SELL	$13.36 - $15.43 $1.86 Million - $2.15 Million	-139,417 Reduced 2.8%	4,847,535 $69.2 Million
Q4 2023 Feb 13, 2024	SELL	$13.36 - $15.43 $5.15 Million - $5.95 Million	-385,746 Reduced 7.37%	4,847,535 $69.2 Million
Q3 2023 Nov 15, 2023	BUY	$15.03 - $16.32 $6.85 Million - $7.44 Million	455,729 Added 9.54%	5,233,281 $81 Million
Q2 2023 Aug 14, 2023	BUY	$15.57 - $17.11 $3.07 Million - $3.37 Million	197,001 Added 4.3%	4,777,552 $75.1 Million
Q1 2023 May 15, 2023	BUY	$15.28 - $16.48 $872,671 - $941,205	57,112 Added 1.26%	4,580,551 $75.5 Million
Q4 2022 Feb 14, 2023	SELL	$12.42 - $15.62 $1.24 Million - $1.56 Million	-99,568 Reduced 2.15%	4,523,439 $70.6 Million
Q3 2022 Nov 14, 2022	BUY	$12.8 - $28.65 $4.85 Million - $10.9 Million	379,182 Added 8.93%	4,623,007 $60 Million
Q2 2022 Oct 27, 2022	BUY	$13.12 - $15.03 $51.4 Million - $58.9 Million	3,920,647 Added 1213.15%	4,243,825 $59.6 Million
Q2 2022 Aug 15, 2022	BUY	$13.12 - $15.03 $51.4 Million - $58.9 Million	3,920,647 Added 1213.15%	4,243,825 $59.6 Million
Q1 2022 Oct 27, 2022	SELL	$13.54 - $15.35 $53.1 Million - $60.2 Million	-3,920,647 Reduced 92.38%	323,178 $4.63 Million
Q1 2022 May 13, 2022	SELL	$13.54 - $15.35 $5.11 Million - $5.79 Million	-377,433 Reduced 53.87%	323,178 $4.63 Million
Q4 2021 Feb 14, 2022	SELL	$13.17 - $16.4 $16.4 Million - $20.4 Million	-1,243,352 Reduced 63.96%	700,611 $9.55 Million
Q3 2021 Nov 15, 2021	BUY	$16.3 - $17.26 $31.7 Million - $33.6 Million	1,943,963 New	1,943,963 $31.8 Million

Others Institutions Holding TAK

# of Institutions

370

Shares Held

73M

Call Options Held

1.68M

Put Options Held

157K

View Full List

About TAKEDA PHARMACEUTICAL CO LTD

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $45.4B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

More about TAK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account